TY - JOUR
T1 - Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes
T2 - A systematic review
AU - Rasmussen, Vinni Faber
AU - Jensen, Troels Staehelin
AU - Tankisi, Hatice
AU - Karlsson, Páll
AU - Vestergaard, Esben Thyssen
AU - Kristensen, Kurt
AU - Nyengaard, Jens Randel
AU - Terkelsen, Astrid Juhl
N1 - Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2021/11
Y1 - 2021/11
N2 - AIMS: To estimate the prevalence of neuropathy in adolescents with type 1 diabetes.METHODS: Systematic collection of published studies exploring the prevalence of large fibre neuropathy (LFN), small fibre neuropathy (SFN), and autonomic neuropathy in adolescents with type 1 diabetes. Following prospective registration (Prospero CRD42020206093), PubMed, EMBASE, and Cochrane Library were searched for studies from 2000 to 2020. PICO framework was used in the selection process (Population: adolescents aged 10-19 years with type 1 diabetes; Intervention: diagnostic methods for neuropathy; Comparison: reference data; Outcome: data on prevalence or comparison). Data were extracted concerning study quality based on available data and established methods for determining and diagnosing various neuropathy types.RESULTS: From 2,017 initial citations, 27 studies (7589 participants) fulfilled eligibility criteria. The study population (47% males) had a diabetes duration between 4.0 and 10.6 years, and HbA1c level between 7.3 and 10.8%, 56-95 mmol/mol. The prevalence of LFN, based on nerve conduction studies, was 10-57%. Based on other tests for neuropathy, the prevalence of LFN and SFN was 12-62%, and that of cardiac autonomic neuropathy was 12-75%.CONCLUSION: The described prevalence of neuropathy in adolescents with type 1 diabetes varied, which can be methodological due to different screening methods and classifications of neuropathy.
AB - AIMS: To estimate the prevalence of neuropathy in adolescents with type 1 diabetes.METHODS: Systematic collection of published studies exploring the prevalence of large fibre neuropathy (LFN), small fibre neuropathy (SFN), and autonomic neuropathy in adolescents with type 1 diabetes. Following prospective registration (Prospero CRD42020206093), PubMed, EMBASE, and Cochrane Library were searched for studies from 2000 to 2020. PICO framework was used in the selection process (Population: adolescents aged 10-19 years with type 1 diabetes; Intervention: diagnostic methods for neuropathy; Comparison: reference data; Outcome: data on prevalence or comparison). Data were extracted concerning study quality based on available data and established methods for determining and diagnosing various neuropathy types.RESULTS: From 2,017 initial citations, 27 studies (7589 participants) fulfilled eligibility criteria. The study population (47% males) had a diabetes duration between 4.0 and 10.6 years, and HbA1c level between 7.3 and 10.8%, 56-95 mmol/mol. The prevalence of LFN, based on nerve conduction studies, was 10-57%. Based on other tests for neuropathy, the prevalence of LFN and SFN was 12-62%, and that of cardiac autonomic neuropathy was 12-75%.CONCLUSION: The described prevalence of neuropathy in adolescents with type 1 diabetes varied, which can be methodological due to different screening methods and classifications of neuropathy.
KW - Adolescents
KW - Neuropathy
KW - Type 1 diabetes
KW - TESTS
KW - GERMAN RESEARCH NETWORK
KW - MICROVASCULAR COMPLICATIONS
KW - CHILDREN
KW - PERIPHERAL-NERVE FUNCTION
KW - NORMAL RANGES
KW - HEART-RATE-VARIABILITY
KW - YOUNG-PEOPLE
KW - CORNEAL CONFOCAL MICROSCOPY
KW - DIAGNOSTIC-CRITERIA
U2 - 10.1016/j.jdiacomp.2021.108027
DO - 10.1016/j.jdiacomp.2021.108027
M3 - Review
C2 - 34429229
SN - 1056-8727
VL - 35
JO - Journal of Diabetes and its Complications
JF - Journal of Diabetes and its Complications
IS - 11
M1 - 108027
ER -